BRACANALYSIS CDX
Total Payments
$83,376
Transactions
1,350
Doctors
903
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $4,604 | 109 | 91 |
| 2023 | $12,982 | 289 | 216 |
| 2020 | $63,096 | 812 | 515 |
| 2018 | $2,209 | 115 | 101 |
| 2017 | $483.59 | 25 | 22 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $43,250 | 22 | 51.9% |
| Food and Beverage | $36,099 | 1,326 | 43.3% |
| Consulting Fee | $2,400 | 1 | 2.9% |
| Travel and Lodging | $1,626 | 1 | 2.0% |
Ad
Manufacturing Companies
- Myriad Genetic Laboratories, Inc. $81,034
- Myriad Women's Health, Inc. $2,341
Product Information
- Type Device
- Total Payments $83,376
- Total Doctors 903
- Transactions 1,350
About BRACANALYSIS CDX
BRACANALYSIS CDX is a device associated with $83,376 in payments to 903 healthcare providers, recorded across 1,350 transactions in the CMS Open Payments database. The primary manufacturer is Myriad Genetic Laboratories, Inc..
Payment data is available from 2017 to 2024. In 2024, $4,604 was paid across 109 transactions to 91 doctors.
The most common payment nature for BRACANALYSIS CDX is "Honoraria" ($43,250, 51.9% of total).